RESEARCH TRIANGLE PARK, N.C.—Quintiles Transnational Corp.
announced last month that it was named CRO of the Year by the U.K.-based SCRIP
Awards, which acknowledges excellence in the biopharmaceutical industry.
Quintiles beat out 13 other nominees in that category. The company provides
clinical and commercial services, consulting, partnerships and alliances to
pharmaceutical, biotechnology and medical device companies and has a network of
23,000 professionals around the world. Quintiles' recent strategic partners
include AstraZeneca, Eisai Co. Ltd. and Allergan.